| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014346 |
| Receipt No. | R000016700 |
| Official scientific title of the study | Longitudinal study across the spectrum of Alzheimer's disease associated with amyloid PET Imaging |
| Date of disclosure of the study information | 2014/06/24 |
| Last modified on | 2018/11/29 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Longitudinal study across the spectrum of Alzheimer's disease associated with amyloid PET Imaging | |
| Title of the study (Brief title) | Longitudinal study across the spectrum of Alzheimer's disease associated with amyloid PET Imaging | |
| Region |
|
|
| Condition | |||||
| Condition | Alzheimer's disease | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | The aim is to evaluate preclinical AD and MCI due to AD using PET amyloid imaging as a beta amyloid biomarker,and to clarify the progression of pre-symptomatic stage to AD dementia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1)To investigate the deposits of beta-amyloid in brain cortex.
2)Degree of impairment of cognitive function correlate with beta-amyloid. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Three-dimensional Dynamic PET images of the brain will be acquired for 60min after intravenous administration of [11C-PIB](about 550 mBq ). | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)The patients had underwent 11C-PIB PET in the past.
2)55years old-90years old,male and female. 3)Written informed consent was obtained from patient or his/her family. |
|||
| Key exclusion criteria | 1)The past and present history of alcoholism and epilepsy
2)The past and present history of psychiatric, disorders, cerebrovascular disease, degenerative disease of the brain and head injury. 3)Severe complication including malignancy, heart failure, hepatic dysfunction, renal dysfunction, endocrine disorders, etc 4)Patients treated with antidepressants, antipsychotics,and long-term sedative-hypnotics 5)The patients that investigators need to exclude. |
|||
| Target sample size | 160 | |||
| Research contact person | |
| Name of lead principal investigator | Shizuo Hatashita |
| Organization | Shonan-Atsugi hospital |
| Division name | Department of neurosurgery |
| Address | Nukumizu118-1 Atsugi-City, Kanagawa, Japan |
| TEL | 046-223-3636 |
| tiken2@shonan-atsugi.jp | |
| Public contact | |
| Name of contact person | Shizuo Hatashita |
| Organization | Shonan-Atsugi hospital |
| Division name | Department of neurosurgery |
| Address | Nukumizu118-1 Atsugi-City, Kanagawa, Japan |
| TEL | 046-297-7576 |
| Homepage URL | |
| tiken2@shonan-atsugi.jp | |
| Sponsor | |
| Institute | Shonan-Atsugi hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of neurosurgery |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016700 |